mmonrealriete
@mmonrealriete.bsky.social
📤 26
📥 30
📝 57
PI of the
#RIETEregistry
about 2 months ago
0
1
0
add a skeleton here at some point
about 2 months ago
0
1
0
about 2 months ago
0
1
1
Should we manage VTE the same way in women with breast, ovarian, or uterine cancer? Data from the
#RIETEregistry
— coming soon in RPTH
about 2 months ago
0
0
0
add a skeleton here at some point
2 months ago
0
2
0
2 months ago
0
1
1
2 months ago
0
1
0
Congrats, Romain and team!
2 months ago
0
0
0
3 months ago
0
1
0
Appearing soon in RPTH
3 months ago
0
2
1
Enoxaparin vs Tinzaparin or Dalteparin in cancer patients with VTE The
#RIETEregistry
experience appearing soon in RPTH
3 months ago
0
1
0
3 months ago
0
0
0
3 months ago
0
0
0
reposted by
mmonrealriete
Behnood Bikdeli, MD, MS
4 months ago
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions |
@jaccjournals.bsky.social
www.jacc.org/doi/10.1016/...
loading . . .
Fibrinolytic Therapy for Thromboembolic Diseases: Approved Indications and Future Directions
https://www.jacc.org/doi/10.1016/j.jacc.2025.07.061
0
2
2
4 months ago
0
1
0
add a skeleton here at some point
4 months ago
0
1
0
Find it here:
www.nature.com/articles/s41...
add a skeleton here at some point
4 months ago
0
1
2
Identifying PE patients at increased risk for CTEPH A new
#RIETEregistry
study Thanks, Stephan and team
4 months ago
0
1
1
The VTE-PREDICT SCORE, externally validated using data from the
#RIETEregistry
Congratulations, Tim and team!
4 months ago
0
2
1
5 months ago
0
1
0
add a skeleton here at some point
5 months ago
0
1
0
add a skeleton here at some point
5 months ago
0
0
1
Impact of cancer site on outcomes in patients with acute VTE The
#RIETEregistry
experience
5 months ago
0
2
2
In patients with cancer-associated VTE, 90-day outcomes largely vary according to cancer sites Another
#RIETEregistry
study appearing soon in JACC Advances
6 months ago
0
0
0
reposted by
mmonrealriete
VTE Specialist Network
6 months ago
Your 5 minute read for today 🤗
@mmonrealriete.bsky.social
pubmed.ncbi.nlm.nih.gov/28120516/
loading . . .
Once versus twice daily enoxaparin for the initial treatment of acute venous thromboembolism - PubMed
Background In patients with acute venous thromboembolism (VTE), it is uncertain whether enoxaparin should be administered twice or once daily. Methods We used the RIETE Registry data to compare the 15...
https://pubmed.ncbi.nlm.nih.gov/28120516/
0
1
1
Prognostic value of baseline PaCO2 levels on outcome in acute pulmonary embolism A new
#RIETEregistry
study appearing soon in Arch Bronconeumol
7 months ago
0
0
0
7 months ago
0
0
0
7 months ago
0
0
0
reposted by
mmonrealriete
Saskia Middeldorp
7 months ago
Interesting data on influence of race from the RIETE registry. After correction for treatment etc, these differences did not show in multi-variate analysis.
#ISTH2025
0
7
4
7 months ago
0
1
0
7 months ago
0
0
0
7 months ago
0
1
1
7 months ago
0
1
1
7 months ago
0
1
1
7 months ago
0
1
1
7 months ago
0
0
0
7 months ago
0
0
0
7 months ago
0
0
0
7 months ago
0
0
0
reposted by
mmonrealriete
Behnood Bikdeli, MD, MS
8 months ago
Must do better for
#PE
risk stratification. In an
@escardio.bsky.social
#EHJ
paper we show that a multimarker calculator🌡️outperforms the ESC model. Great leadership by
#DavidJimenez
@mmonrealriete.bsky.social
#RIETE
! 👇:
tinyurl.com/trpmzbrd
0
2
2
add a skeleton here at some point
9 months ago
0
1
0
VTE patients with low LDL-cholesterol levels are at increased risk for major bleeding during anticoagulation, particularly hematoma Another study from the
#RIETEregistry
Congratulations, Carmine and team!
9 months ago
0
0
1
Our manuscript on the impact of hemoglobin values at baseline and clinical outcomes in patients with acute venous thromboembolism has been accepted for publication in the Am J Hematol Congratulations, RIETE team!
9 months ago
0
2
1
add a skeleton here at some point
9 months ago
0
1
1
Obese patients with acute PE have a lower mortality rate Find it here:
www.rpthjournal.org/action/showP...
loading . . .
https://www.rpthjournal.org/action/showPdf?pii=S2475-0379%2825%2900042-1
9 months ago
0
1
2
9 months ago
0
0
0
reposted by
mmonrealriete
Unidad de ETV HGUGM
10 months ago
@luciaordieres.bsky.social
@mmonrealriete.bsky.social
#VTE
#thrombosis
#VTESky
#IMSky
#HemeSky
0
1
1
reposted by
mmonrealriete
Marc Carrier, MD
10 months ago
Prof.
@isabellemahe.bsky.social
presents API-CAT at
@accintouch.bsky.social
published in
@nejm.org
: Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose for preventing recurrent VTE, with less clinically relevant bleeding 🩸in cancer patients
www.nejm.org/doi/full/10....
0
10
9
reposted by
mmonrealriete
10 months ago
@acc25.bsky.social
Isabelle Mahe presents API-CAT Low dose Apixaban noninferior to high dose for recurrent VTE and superior for lower bleeding-another win!
0
8
3
reposted by
mmonrealriete
NEJM.org
10 months ago
NEJM Editorial Fellow Harleen Marwah, MD, summarizes the API-CAT trial. Read the full trial results:
nej.md/41YkRZK
#ACC25
#MedSky
#CardioSky
@accintouch.bsky.social
loading . . .
1
5
6
Load more
feeds!
log in